Plasmid DNA For Cell & Gene Therapy: It All Starts Here
Critical starting materials, such as plasmid DNA, play a pivotal role in advancing cell and gene therapy, regenerative medicine, and vaccine development. Ensuring their quality and consistency is vital for achieving long-term clinical success.
Watch the informative webinar below featuring Matt Howard, Vice President of Manufacturing, and Tyler Kozisek, Ph.D., Senior Scientist in R&D, who will delve into the strategic importance of partnering with a manufacturing expert to support your therapy’s journey from research to clinical success.
The session will explore how tailored manufacturing solutions can enhance program outcomes, leverage cutting-edge technologies for research and discovery, and optimize preclinical applications. Following the presentations, a live panel session will provide an opportunity to address your specific questions. Don’t miss this chance to gain valuable insights and strategies to maximize the success of your therapeutic programs.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.